The American Chemical Society (ACS) ended 2020 with strong financial results, in spite of COVID-19-related challenges. ACS generated a change in net assets without donor restrictions from operations of $62.5 million on total revenues of $632.1 million. This strong result was attributable to a combination of robust revenues from the information services divisions and continued expense discipline across all Society program and administrative units. The positive financial results allowed the Society to continue strategic investments in its mission-driven activities and member services.
The Society’s financial position strengthened in 2020. Net assets without donor restrictions increased from $446.2 million at Dec. 31, 2019, to $588.7 million as of Dec. 31, 2020. This increase resulted primarily from the $62.5 million operating contribution and net investment gains of $66.2 million. The Society ended 2020 in full compliance with all of the ACS Board-approved financial guidelines.
The audited financial statements and additional finance-related resources can be accessed on the Society’s financial information website.
ACS is grateful for the generous support provided by donors and sponsors for its programs and awards. To see the names of those who contributed, please view the list of 2020 sponsors of ACS national awards.